Effect of previous and current vaccination against influenza A(H1N1) pdm09, A(H3N2), and B during the post-pandemic period 2010-2016 in Spain

被引:17
|
作者
Gherasim, Alin [1 ]
Martinez-Baz, Ivan [2 ,3 ]
Castilla, Jesus [2 ,3 ]
Pozo, Francisco [4 ]
Larrauri, Amparo [1 ,3 ]
机构
[1] Carlos III Hlth Inst, Natl Epidemiol Ctr, Madrid, Spain
[2] IdiSNA Navarra Inst Hlth Res, Inst Salud Publ & Laboral Navarra, Pamplona, Spain
[3] Inst Hlth Carlos III, CIBER Epidemiol & Salud Publ CIBERESP, Madrid, Spain
[4] Carlos III Hlth Inst, WHO Natl Influenza Ctr, Natl Influenza Reference Lab, Natl Ctr Microbiol, Madrid, Spain
来源
PLOS ONE | 2017年 / 12卷 / 06期
关键词
TEST-NEGATIVE DESIGN; SEASON; VACCINES; CIRCULATION; PROTECTION; EFFICACY;
D O I
10.1371/journal.pone.0179160
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Background Recent studies suggest that the protective effect of the current influenza vaccine could be influenced by vaccination in previous seasons. We estimated the combined effect of the previous and current influenza vaccines from the 2010-2011 season to the 2015-2016 season in Spain. Methods We performed a test-negative case-control study in patients >= 9 years old. We estimated the influenza vaccine effectiveness (IVE) against influenza A(H1N1) pdm09, A(H3N2), and B virus. Results We included 1206 influenza A(H1N1) pdm09 cases, 1358 A(H3N2) cases and 1079 B cases. IVE against A(H1N1) pdm09 virus in the pooled-season analysis was 53% (95% Confidence Interval (CI): 21% to 72%) for those vaccinated only in the current season and 50% (95% CI: 23% to 68%) for those vaccinated in the both current and previous seasons. Against the influenza A(H3N2) virus, IVE was 17% (95% CI: -43% to 52%) for those vaccinated only in the current season and 3% (95% CI: -33% to 28%) for those vaccinated in both seasons. Regarding influenza B, we obtained similar IVEs for those vaccinated only in the current and those vaccinated in both seasons: 57% (95% CI: 12% to 79%) and 56% (95% CI: 36% to 70%), respectively. Conclusion Our results suggested no interference between the previous and current influenza vaccines against A(H1N1) pdm09 and B viruses, but a possible negative interference against A (H3N2) virus.
引用
收藏
页数:16
相关论文
共 50 条
  • [31] 2012/13 influenza vaccine effectiveness against hospitalised influenza A(H1N1)pdm09, A(H3N2) and B: estimates from a European network of hospitals
    Rondy, M.
    Launay, O.
    Puig-Barbera, J.
    Gefenaite, G.
    Castilla, J.
    Donati, K. de Gaetano
    Galtier, F.
    Hak, E.
    Guevara, M.
    Costanzo, S.
    Moren, A.
    EUROSURVEILLANCE, 2015, 20 (02) : 9 - 20
  • [32] Influenza A(H1N1)pdm09 Vaccination in Pregnancy and Risk of Fetal Death
    Pasternak, Bjorn
    Svanstrom, Henrik
    Molgaard-Nielsen, Ditte
    Krause, Tyra G.
    Emborg, Hanne-Dorthe
    Melbye, Mads
    Hviid, Anders
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2012, 21 : 383 - 383
  • [33] International Laboratory Comparison of Influenza Microneutralization Assays for A(H1N1) pdm09, A(H3N2), and A(H5N1) Influenza Viruses by CONSISE
    Laurie, Karen L.
    Engelhardt, Othmar G.
    Wood, John
    Heath, Alan
    Katz, Jacqueline M.
    Peiris, Malik
    Hoschler, Katja
    Hungnes, Olav
    Zhang, Wenqing
    Van Kerkhove, Maria D.
    CLINICAL AND VACCINE IMMUNOLOGY, 2015, 22 (08) : 957 - 964
  • [34] Predictors of influenza in the adult population during seasonal and A(H1N1) pdm09 pandemic influenza periods
    Gefenaite, G.
    Tacken, M.
    Kolthof, J.
    Mulder, B.
    Korevaar, J. C.
    Stirbu-Wagner, I.
    Bos, J.
    Stolk, R. P.
    Hak, E.
    EPIDEMIOLOGY AND INFECTION, 2014, 142 (05): : 950 - 954
  • [35] IMMUNOGRAPH-BASED ANALYSIS OF THE INFLUENZA A(H1N1)pdm09 VACCINE STRAIN IMMUNOGENICITY IN THE PANDEMIC AND POST-PANDEMIC PERIOD (2009-2014)
    Vakin, V. S.
    Amosova, I., V
    Vojcekhovskaya, E. M.
    Timoshicheva, T. A.
    Vasileva, A. A.
    Pozdnyakova, M. G.
    Lyalina, L., V
    Marchenko, V. A.
    Nikonorov, I. Yu
    Grudinin, M. P.
    INFEKTSIYA I IMMUNITET, 2022, 12 (01): : 158 - 164
  • [36] Pandemic Influenza A(H1N1)pdm09 Seroprevalence in Sweden before and after the Pandemic and the Vaccination Campaign in 2009
    Morner, Andreas
    Brave, Andreas
    Kling, Anna-Maria
    Kuhlmann-Berenzon, Sharon
    Krook, Katarina
    Hedenskog, Mona
    Silhammar, Irene
    Ljungman, Margaretha
    Ortqvist, Ake
    Andersson, Soren
    Brytting, Maria
    Thorstensson, Rigmor
    Linde, Annika
    PLOS ONE, 2012, 7 (12):
  • [37] Neurological events related to influenza A (H1N1) pdm09
    Cardenas, Graciela
    Luis Soto-Hernandez, Jose
    Diaz-Alba, Alexandra
    Ugalde, Yair
    Merida-Puga, Jorge
    Rosetti, Marcos
    Sciutto, Edda
    INFLUENZA AND OTHER RESPIRATORY VIRUSES, 2014, 8 (03) : 339 - 346
  • [38] Demographic Shift of Influenza A(H1N1)pdm09 during and after Pandemic, Rural India
    Broor, Shobha
    Sullender, Wayne
    Fowler, Karen
    Gupta, Vivek
    Widdowson, Marc-Alain
    Krishnan, Anand
    Lal, Renu B.
    EMERGING INFECTIOUS DISEASES, 2012, 18 (09) : 1472 - 1475
  • [39] Influenza A(H1N1)pdm09 virus: therapeutics and challenges
    Saxena, Shailendra K.
    Kotikalapudi, Rosaiah
    Tiwari, Sneham
    Muvva, Charuvaka
    FUTURE VIROLOGY, 2012, 7 (10) : 947 - 950
  • [40] The 2015 influenza A (H1N1) pdm09 outbreak in India
    Murhekar, Manoj
    Mehendale, Sanjay
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2016, 143 : 821 - 823